GOVERNMENT says it has experienced a delay in the shipment of Zidvovudine/Lamivudine, an ARV combination agent, and as such, individuals who are virally suppressed and are on the same drug have been switched to Tenofovir Disoproxil Fumarate. Ministry of Health Permanent Secretary for Technical Services Professor Luckson Kasonka says such individuals can also be switched to Tenofovir Alaienamide/Emtricitabine/Dolutegravir (TAFED). And director, infectious diseases at the ministry Prof Lloyd Mulenga has assured people living with HIV that the drug government is switching to is a better option, as the one out of stock has some complications. In a letter dated September 9 and addressed to provincial health directors, senior medical superintendents, district medical officers and implementing partners, Prof Kasonka said the...